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Jahangir AM Khan1,2,3* and Rashidul Alam Mahumud1,2Abstract
South-East Asian Regional (SEAR) countries range from low- to middle-income countries and have considerable
differences in mix of public and private sector expenditure on health. This study intends to estimate the
income-elasticities of healthcare expenditure in public and private sectors separately for investigating whether
healthcare is a ‘necessity’ or ‘luxury’ for citizens of these countries. Panel data from 9 SEAR countries over 16 years
(1995-2010) were employed. Fixed- and random-effect models were fitted to estimate income-elasticity of public,
private and total healthcare expenditure. Results showed that one percent point increase in GDP per capita increased
private expenditure on healthcare by 1.128%, while public expenditure increased by only 0.412%. Inclusion
of three-year lagged variables of GDP per capita in the models did not have remarkable influence on the findings.
The citizens of SEAR countries consider healthcare as a necessity while provided through public sector and a luxury
when delivered by private sector. By increasing the public provisions of healthcare, more redistribution of healthcare
resources can be ensured, which can accelerate the journey of SEAR countries towards universal health coverage.
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In the World Health Assembly, the World Health
Organization (WHO) urges (among other points) the mem-
ber states “to ensure that health-financing systems include a
method for prepayment of financial contributions for health
care, with a view to sharing risk among the population and
avoiding catastrophic health-care expenditure and impover-
ishment of individuals as a result of seeking care” [1]. In the
low- and middle-income countries (LMICs), in absence of
social health insurance, government budget is the largest
share for funding healthcare where pre-payment financial
contribution with scope of risk pooling mechanism is incor-
porated. The role of government on financing healthcare is
thus a major concern in LMICs, including most of the* Correspondence: jahangir.khan@icddrb.org
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reproduction in any medium, provided the origcountries in South-East Asian Region (SEAR), for achieving
universal health coverage.
Different mix of public and private expenses constitutes
the total health expenditure (THE) in any country [2]. The
commonly found healthcare financing agents are General
Government Expenditure on Health (GGEH), Ministry of
Health (MoH) and households (out-of-pocket expend-
iture). In addition, social security fund, private health insur-
ance and NGOs are financing healthcare in some of the
countries. GGEH is the largest funder in almost all coun-
tries in SEAR, followed by Ministry of Health. Households
spend a major share of THE in Bangladesh, India, Maldives
and Indonesia. The trends of THE in these countries are
influenced by the private expenditure on health [2].
The governments of LMICs generally allocate small share
of their budget on health, while people invest more on
health privately, especially as out-of-pocket payments [2]. It
needs to notice here that in response to the Structural
Adjustment Programmesa of the World Bank and the Inter-
national Monetary Fund, many developing countries since
1980s reduced public spending on health and promoted. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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strong reason of increase in private expenditure on health
in LMICs, including in a number of SEAR countries.
People in different income levels within a country may
demand healthcare differently and they may also re-
spond differently to their income changes [3]. Further,
the effects of income changes are likely to be different
on healthcare expenditure in private and public sectors
since co-payments (i.e. out-of-pocket) are generally
higher for healthcare from private providers. Costa-Font
et al. (2009) argued that “if healthcare is a necessity that
necessitates more redistribution of healthcare resources
and arguably greater public involvement in healthcare” [4].
It was further argued that “the value of income elasticity
provides insight into the optimal level of health expendi-
tures in the economy and the efficient proportion of
public and private health spending” [4]. Considering the
variations in income level and different mix of private and
public sector involvement in healthcare in SEAR coun-
tries, this study intends to estimate the income-elasticities
of healthcare expenditure in public and private sectors
separately for investigating whether healthcare is a ‘luxury’
or ‘necessity’ for citizens of these countriesb.
Previous studies
This section provides an overview of what kinds of stud-
ies on income-elasticity of healthcare were carried out
and the general findings from those studies. Several earl-
ier studies estimated the income-elasticity of healthcare
using country-level data, which showed strong and posi-
tive relationship between national income and aggregate
expenditure on health [5-17]. Most of those studies in-
vestigated the developed countries and the general find-
ing was that income-elasticity estimates exceeded unity,
implying that healthcare was a luxury good [5-17]. How-
ever, Farag et. al. (2012) studied the low-, middle- and
high-income countries separately and found that the
low-income countries were least responsive to income-
levels and the middle-income countries were the most
responsive ones [16]. All of these three categories of
countries had lower income-elasticity than unity, imply-
ing that healthcare was a necessity. In estimating the
income-elasticity of healthcare, a number of control var-
iables, like demographic structure, health conditions etc.
were considered in the regression models [5-17]. The
most well-known study on income-elasticity of health-
care was done by Newhouse (1977), which included
data only for one year from 13 developed countries [6].
This study found that healthcare was a ‘luxury’ (elasticity
more than one). In a more recent commentary, Newhouse
(2006) supported the view that organizational factors of
healthcare delivery and financing mechanisms had a sig-
nificant role on the magnitude of healthcare expenditure
[18]. Gerdtham (1992), using cross-sectional data fromOECD countries in 1985, estimated the income-elasticity to
more than unity [17]. Getzen (2000) attempted to resolve
the debate on relationship between income and health ex-
penditure by estimating income-elasticity using nested
multilevel model and found that healthcare was a luxury at
country-level and necessity at individual-level [19]. While
most of the studies in this area included developed countries
in their analysis, few took even the developing countries into
consideration [16,20]. By analyzing data from 173 countries
for period 1995-2006, Fagar et al. (2012) observed that
healthcare was a necessity in the low- and high-income
countries with income-elasticity of 0.515 and 0.644 respect-
ively [16]. Xu and Saksena (2011) analyzed data from 143
countries, separated into income groups over period 1995-
2008 and found healthcare in low-income countries as a
luxury and in middle- and high-income countries as a ne-
cessity [20]. Many of the studies mentioned above generally
controlled for a number of variables, such as, sex- and age-
structure, health systems, unobserved heterogeneity when
estimated the income-elasticity of healthcare [5,16,19,20].
In sum, previous studies, which investigated the de-
terminants of health expenditure and estimated the
income-elasticity of healthcare, mostly studied the health
expenditure in total, not public and private spending separ-
ately. Inference about the relationship between income and
health expenditure in public and public sectors was there-
fore difficult to make from those studies directly. It is thus
important to disaggregate THE into public and private sec-
tors for understanding, if and to what extent health ex-
penditure in private and public sectors are sensitive to
income changes. As observed in the above-mentioned lit-
erature, most of the studies found that healthcare was a
luxury though some found an opposite relationship be-
tween income and health expenditure. However, the
income-elasticity of private and public expenditure on
healthcare had not been studied enough though the deci-
sion making procedure on health spending in those two
sectors are quite different and the impact of income
change on such spending are also likely to be different.
Conceptual framework
Change in income influences the consumption behavior
of households as well as resource allocation decision of
any nations. Healthcare is generally provided by both
public and private sectors with different degrees of mix
in different countries. Households with higher income
level have more freedom of choice while making deci-
sion on healthcare purchase. It is thus more likely that
households with higher income choose healthcare from
private sector where quality (shorter waiting time, clean
facilities etc.) of care might be better though price is
high. It is expected that higher income may results in
significantly higher healthcare expenditure. On the con-
trary, people with low-income are more likely to choose
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payments (user fee). Any increase in income of low-
income people may thus increase healthcare expenditure,
but at a lower rate. Further, the government’s resource al-
location in healthcare is subject to budget negotiation
with other ministries (like, education, defense, housing
etc.), which generally takes a longer time. Consequently,
government may not put a proportionally high priority in
health as response to the national income increase. It is
thus expected that private expenditure on health which is
mostly decided by households may increase at a higher
rate than public expenditure as response to the increase
in income.
Methods
In this current study, for addressing the objective, we
intended to estimate to what extent private and public
expendituresc on health change as a response to changes
in income level. Income (GDP per capita) elasticity on
private and public spending on health was therefore esti-
mated using multiple regression analyses. Data and esti-
mation techniques are explained below.
Data and variable
The present study analyzed annual panel data from 9
SEAR member countries (Bangladesh, Bhutan, India,
Indonesia, Maldives, Nepal, Sri Lanka, Thailand and
Timor-Leste) during the period 1995 -2010. The data on
determinants of health expenditure used in the empirical
analysis were sourced from the World Development
Indicators and the data on health expenditure was extracted
from National Health Accounts of the World Health
organization [2,21]. It needs to be noticed that Myanmar,
though a SEAR country, was excluded from the analyses as
data on some independent variables were missing.
In this study, total per capita health expenditure and
such expenditure separated into per capita public and
private health expenditure were predicted by national in-
come (per capital GDP at international dollar and at
constant price), demographic structure (share of female,
share of elderly population aged 65 years and above as
well as share of urban inhabitants in total population)
and health condition (life expectancy at birth in years).
The models and estimation strategy
Panel data (also known as longitudinal or cross sectional
time-series data) is a dataset in which the behavior of en-
tities (states, companies, individuals, countries, etc.) is ob-
served across time. Panel data allows us to control for
variables we cannot observe or measure like variables that
change over time but not across countries [22]. In this
study, using a strongly balanced panel data with 9 SEAR
countries over 16 years, fixed-effect model (FEM) and ran-
dom effect models (REM) were employed for estimation.The estimations were made using three dependent
variables separately, i.e. total, public and private health
expenditure per capita. The explanatory variables in-
cluded national income level, demographic structure and
health condition. Such variables were used in earlier
studies for predicting health expenditure or related ones
[5,17,19,20,23]. Decision on health expenditure is nor-
mally followed by income change. We, therefore, applied
even dynamic models including three-year lagged data
on national income while estimated health expenditure
per capita [17,20,23].
Fixed effect model (FEM)
Fixed-effect model represents the observed quantities in
terms of explanatory variables that were treated as if the
quantities were non-random. Equation (1) expresses the
model considering subscripts i and t were used for indi-
cating country and year respectively in a panel data set:
yit ¼ βxit þ αi þ uit ð1Þ
where yit was the dependent variable (natural log of
health expenditure per capita), xit was natural log of GDP
per capita and a number of control variables, namely,
demographic structure (female population, urban popu-
lation and elderly population as a percentage of total
population) health condition (life expectancy at birth). β
was the coefficient for any independent variable, αi repre-
sented unknown intercept for any entity (country) and uit
was the error term.
Random-Effect Model (REM)
The random effect model, unlike the fixed effect model,
assumed the variation across countries to be random
and uncorrelated with the predictor or independent vari-
ables included in the model. If we had reason to believe
that differences across entities (countries) had some in-
fluence on our dependent variable then we should have
used random effect. An advantage of random effect
model was that we could include time invariant vari-
ables. The random effect model is as follows:
yit ¼ βxit þ ai þ uit þ ∈it ð2Þ
where, u was a within country error and ε is a between
country error, remaining notations were same as the
fixed effect model expressed in equation (1). Random
effect assumed that the countries error term was not
correlated with the predictors which allowed for time-
invariant variables to play a role as explanatory variables.
Random effect model was estimated by Generalized
Least Squares (GLS) while fixed effect model was esti-
mated by ordinary least squares with differential inter-
cept dummies for country and year dimensions. The
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between fixed-effect and random-effect models.
Results
Descriptive statistics
Table 1 shows the descriptive statistics of the variable of
interest in SEAR countries. Average values of the vari-
ables in 1995-2010 with 95% confident interval, and
number of observations (on the basis of which the statis-
tics were calculated) were presented for each country
separately as well as for all countries. The income of
the countries ranged between US$ 938.4 (Nepal) and
US$ 6,355.6 (Thailand). Among these 9 countries Maldives
experienced the largest total health expenditure per capita
(US$ 333.0) while Bangladesh had the lowest expenditure
(US$ 32.3). The trends of public and private expend-
iture as well as their total in each country were presented
in Figure 1. Demographic characteristics showed that
some countries had higher proportion of female (Nepal,
Sri Lanka and Thailand) while most of the countries had
higher number of male population. Indonesia experienced
the largest urbanization with 43.9% population in the
urban areas. Nepal on the contrary had only 14.3% urban
people. Thailand had largest proportion of elderly popula-
tion (7.5%), followed by Sri Lanka (7.0%). Lowest propor-
tion of elderly was observed in Timor-Leste (2.6%). Life
expectancy at birth was high in Thailand and Sri Lanka
with 73.0 years and 72.3 years respectively, when Timor-
Leste had the lowest (57.8 years).
Correlation matrix
The correlation matrix of independent variables showed
a rather simplistic description of the nature of the inter-
relationship among the independent variables, reported
as being multicollinear problem (Table 2). None of the
variables showed strong correlation with any other vari-
ables while referring to more than 0.85 as a high degree
of relationship (correlation coefficient, r > 0.85) between
variables for multicollinearity [24].
Econometric estimation
Estimated relationship between income and health ex-
penditure in total and separated into public and private
were presented in Tables 3 and 4. Hausman tests for
identifying the better estimation model between FEM
and REM showed that FEM was favored for estimating
total and public expenditure, while any of FEM and
REM could be appropriate for estimating private ex-
penditure model [22]. GDP per capita showed positive
effect on any of total, public and private expenditure
on health. Regression coefficients suggested that the
income-elasticity of total expenditure, i.e. one percent
point increase in GDP per capita increased total and
public expenditure by 0.73% and 0.412% respectively.The private expenditure on health increased by 1.128%
in response to a one percent point increase in GDP
per capita.
The control variables i.e. demographic structure (share
of female, elderly population and urban population) and
health condition (life expectancy at birth) showed ex-
pected effect on any kind of health expenditures. It was
observed that share of elderly population in total popu-
lation had positive effect on total and public expend-
iture, but negative effect on private expenditure on
health. When included three-year lagged variable of in-
come level (Table 4), we still found in the fixed effect
model that the public spending in the reporting years
was income-inelastic (0.918) and the private spending
even more elastic (1.452).
Discussion
Findings from the current analysis showed that the pub-
lic expenditures were inelastic in relation to national in-
come in SEAR countries, which implied that healthcare
was a necessity for citizens in SEAR countries, while
provided through the public sector. The private expend-
iture, on the contrary, was elastic, i.e. healthcare was
considered as a luxury by the citizens when they could
make their own decision mostly as individuals and house-
holds. Our models with three-year lagged data on national
income did not show any significant change in income-
elasticities on total and public health expenditure.
For estimating the income-elasticity of healthcare we
constructed the regression models, based on a number
of previously used models, where health expenditure had
been predicted by national income while controlled for
variations in demographic structure of the country and
health condition [5-17,20,23]. This current study utilized
published data on country level. These data were not
sufficiently and appropriately available on some of the
key control variables of interests. For instance, classifica-
tion of age groups were based on ability to work (0-15,
16-64 and 64+ years), not focusing on health outcomes.
Further, some previous studies controlled for literacy or
education levels [25,26]. But we could not include this
variable in this analysis as it was not found for all coun-
tries and years.
A good number of studies estimated income-elasticity
of healthcare, but mostly using data from developed
countries either employing cross-sectional or panel data
[5-17]. These studies found a positive relationship be-
tween income and healthcare expenditure, but while
some studies found healthcare a ‘necessity’, others found
that a ’luxury’. Remarkably, very few studies utilized data
from developing countries [16,20]. Further, studies that
analyzed data from private and public sectors separately
were rarely found [20]. Keeping the debate that if health-
care is a luxury or necessity in mind, Getnez (2000)
Table 1 Variables employed in the analysis by countries
Variables1) Country
Health expenditure per capita2) Bangladesh Bhutan India Indonesia Maldives Nepal Sri Lanka Thailand Timor-Leste All
Public 12.5 137.6 29.0 39.5 226.3 21.0 64.5 166.1 84.6 86.8
(10.2-14.7) (105.8-169.4) (23.3-34.8) (31.5-47.4) (161.2-291.3) (16.6-25.3) (54.6-74.3) (129.8-202.4) (72.6-96.5) (72.5-101.0)
Private 19.9 34.1 54.8 29.3 106.8 28.6 52.8 56.1 7.6 43.3
(15.0-24.7) (31.7-36.6) (46.7-63.0) (25.1-33.5) (95.8-117.7) (27.4-29.7) (45.7-59.9) (50.5-61.7) (6.2-9.1) (38.5 -48.2)
Total 32.3 171.7 83.89 68.8 333.0 49.5 117.2 222.2 92.2 130.1
(25.3-39.39) (139.2-204.3) (70.1-97.7) (56.8-80.7) (257.7-408.3) (44.4-54.6) (100.4-134.0) (189.5-255.0) (79.4-105.0) (112.4-147.8)
GDP per capita2) 1123.1 3348.2 2106.8 3090.3 5374.2 938.4 3435.6 6355.6 1077.5 3034.5
(1003.4-1242.8) (2871.7-3824.7) (1813.4-2400.3) (2842.4-3338.1) (4591.1-6157.2) (893.8-982.9) (3049.9-3821.3) (5919.0-6792.2) (986.7-1168.3) (2717.4-3351.6)
Female population, %3) 48.9 48.2 48.2 50.1 49.6 50.3 50.3 50.7 48.9 49.4
(48.8-49.0) (47.7-48.7) (48.2-48.3) (50.0-50.1) (49.2-49.4) (50.2-50.3) (50.2 - 50.5) (50.6-50.8) (48.8-48.9) (49.3 -49.6)
Urban population, %3) 24.9 28.4 28.7 43.9 32.1 14.3 15.5 31.9 25.4 27.2
(23.8-26.0) (25.9-30.9) (27.9-29.5) (41.6-46.3) (29.4-34.8) (13.3-15.2) (15.3-15.8) (31.3-32.6) (24.4-26.3) (25.8 -28.7)
Elderly population, %3) 4.2 4.4 4.5 4.9 4.3 3.7 7.0 7.5 2.6 4.8
(4.1-4.3) (4.2-4.5) (4.3-4.6) (4.7-5.2) (3.9-4.7) (3.6-3.9) (6.7-7.4) (7.0-8.1) (2.4-2.7) (4.5-5.1)
Life expectancy at birth, years 65.9 62.9 62.7 66.6 72.2 63.7 72.3 73.0 57.8 66.3
(64.8-67.0) (61.2-64.7) (61.8-63.6) (65.7-67.4) (70.2-74.1) (61.8-65.6) (71.1-73.4) (72.7-73.3) (56.0-59.6) (65.4-67.2)
N 16 16 16 16 16 16 16 16 (13-17) 144-153
Notes: 1)Mean and 95% confidence intervals are reported, 2)In international dollar, 3)As a percentage of total population.
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Figure 1 Trend of health expenditure per capita (PPP adjusted US$) in SEAR Countries over 1995 -2010.
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care expenditure using multi-level analysis and found that
healthcare was a luxury at country-level and necessity at
individual level [19].The findings from the current study were comparable
with some other studies [16,20]. Like Fager et. al. (2012)
and Xu and Saksena (2011), we found that healthcare
was a ‘necessity’ in low- and middle-income countries
Table 2 Correlation matrix of independent variables used in the analyses
Variables GDP per capita Female population Elderly population Urban population Life expectancy at birth
GDP per capita 1.000
Female population 0.298 (0.0002)*** 1.000
Elderly population 0.708 (0.000)*** 0.559 (0.000)*** 1.000
Urban population 0.457 (0.000)*** -0.109 (0.178) 0.113 (0.163) 1.000
Life expectancy at birth 0.778 (0.000)*** 0.491 (0.000)*** 0.791 (0.000)*** 0.221 (0.0062)*** 1.000
Notes: ***, ** and * denotes significant at 1%, 5% and 10% risk level respectively.
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[16,20]. Xu and Saksena (2011) separated total health
expenditure into public and private (precisely, out-of-
pocket) like the current study [20]. The authors found
that low-income countries considered healthcare as a
‘luxury’ and middle-income countries as a ‘necessity’
[20]. This current study found that SEAR countries,
which ranged from low- to middle-income levels, regarded
healthcare as a ‘necessity’ while delivered through public
sector. In a static model, Xu and Saksena (2011) ob-
served that income-elasticity of private healthcare (out-
of-pocket expenditure) was more than unity (1.098) in
low-income countries and closed to unity (0.842-0.869)
in the middle-income countries [20]. However, income-
elasticities reduced significantly in the dynamic model in
low-income and middle-income countries. Our current
study consistently found that healthcare through private
sector was income-elastic, in both static and dynamic
models (Tables 3 and 4), implying that healthcare was a
‘luxury’.Table 3 Estimated effect of national income (GDP per capita)
Determinants Model 1
Total expenditure
FEM REM F
Constant - 9.442(0.000)*** - 8.312(0.000) *** - 7.838
GDP per capita1) 0.7293(0.000) *** 0.7255(0.000)*** 0.412
Female population 0.1087(0.002)** 0.0864(0.015)*** 0.068
Urban population 0.0240(0.001)*** 0.0205(0.002)** 0.026
Elderly population 0.0749(0.041)* 0.0634(0.089)* 0.206
Life expectancy at birth 0.0297(0.001)*** 0.0323(0.000)*** 0.054
Observation (N) 140 140
R2(R-squared)
Within 0.8651 0.8643 0
Between 0.4924 0.5093 0
Overall 0.5501 0.5666 0
F-statistics 161.61(0.000)*** - 176.66
Wald chi2 (5) - 686.58 (0.000)***
Hausman test Chi2 (5) = 26.37 (0.0001)***
Notes: 1) Natural logged, ***, ** and * denotes significant at 1%, 5% and 10% risk leNational Health Accounts showed that public expend-
iture generally contributed less to the total health expend-
iture in a number of SEAR countries [2]. The private
expenditure, mostly spent as out-of-pocket payments, was
the most common mechanism for healthcare funding in
these countries. Introducing the healthcare financing
mechanisms, which can reduce the burden of out-of-
pocket payments to an affordable level for citizens, ap-
peared to be a challenge in many low- and middle-income
countries, including those in SEAR though it is a funda-
mental component of universal health coverage. Political
commitment is considered to be essential in this regard. It
can be argued that increasing public provisions for health-
care can increase the scope of redistribution of healthcare
resources since such provision is financed by pooled fund,
mostly taxes, where people from different income groups
contribute. Redistribution from a pooled fund can be
across rich and poor as well as across healthy and sick
people [27]. The magnitude of redistribution depends on
the distribution of healthcare utilization across differenton health expenditure per capita1) in SEAR countries
Model 2 Model 3
Public expenditure Private expenditure
EM REM FEM REM
(0.001)*** - 7.837(0.000)*** - 22.029(0.000)*** - 21.34(0.000)***
(0.004)*** 0.449(0.001)*** 1.128(0.000)*** 1.101(0.000)***
(0.091)* 0.067(0.100)* 0.323(0.000)*** 0.309(0.000)***
(0.002)*** 0.027(0.000)*** 0.014(0.101)* 0.010(0.208)
(0.000)*** 0.192(0.000)*** - 0.301(0.000)*** - 0.288(0.000)***
(0.000)*** 0.052(0.000)*** 0.029(0.009)*** 0.032(0.002)***
140 140 140 140
.8752 0.8750 0.6859 0.6853
.2837 0.2974 0.4195 0.4462
.3875 0.4005 0.4346 0.4590
(0.000)*** - 55.04(0.000)*** -
- 830.37(0.000)*** - 280.63 (0.000)***
Chi2 (5) = 13.11 (0.022)* Chi2 (5) = 4.04 (0.5431)
vel respectively.
Table 4 Estimated effect of national income (natural logged GDP per capita) considering three-year lagged sustainable
income change as well as demographic structure and health condition on health expenditure per capita1) in SEAR countries
Explanatory variables Model 1 Model 2 Model 3
Total expenditure Public expenditure Private expenditure
FEM REM FEM REM FEM REM
Constant - 10.579(0.000)*** - 4.698(0.028)*** - 9.009(0.000)*** - 11.218(0.001)*** -22.458(0.000)*** - 2.669(0.310)
GDP per capita1) 0.918(0.002)*** 1.862(0.018)*** 0.684(0.058)** 2.001(0.114) 1.452(0.000)*** 1.939(0.046)**
Lag 1 of GDP per capita1) - 0.062(0.834) - 0.429(0.598) - 0.155(0.668) 0.007(0.996) - 0.239(0.495) - 1.221(0.224)
Lag 2 of GDP per capita1) - 0.034(0.734) - 0.026(0.927) - 0.012(0.924) - 0.007(0.988) - 0.057(0.625) - 0.059(0.868)
Lag 3 of GDP per capita1) 0.036(0.640) 0.009(0.967) 0.022(0.816) - 0.158(0.634) - 0.016(0.858) 0.217(0.395)
Female population 0.128(0.000)*** - 0.005(0.915) 0.092(0.035)** 0.083(0.234) 0.326(0.000)* - 0.057(0.291)
Urban population 0.025(0.002)*** - 0.025(0.000)*** 0.030(0.002)*** - 0.026(0.000)*** 0.008(0.402) - 0.025(0.000)***
Elderly population 0.061(0.135) - 0.234(0.000)*** 0.197(0.000)*** - 0.316(0.000)*** - 0.319(0.000)*** - 0.151(0.001)***
Life expectancy at birth 0.018(0.139) 0.005(0.680) 0.038(0.012)*** - 0.015(0.421) 0.036(0.014)*** 0.054(0.000)***
Observation (N) 125 125 125 125 125 125
R2(R-squared) - - - - - -
Within 0.8548 0.3816 0.8542 0.2026 0.6807 0.3627
Between 0.4869 0.8485 0.2897 0.7167 0.4507 0.7119
Overall 0.5363 0.8037 0.3936 0.7091 0.4500 0.6629
F-statistics 79.46(0.000)*** - 79.08 (0.000)*** - 28.78(0.000)*** -
Wald chi2 (5) - 475.01(0.000)*** - 282.81(0.000)*** - 228.11(0.000)***
Hausman test Chi2 (8) =102.88 (0.000)*** Chi2 (8) =108.51 (0.000)*** Chi2 (8) =104.02 (0.000)***
NB: 1) Natural logged, ***, ** and * denotes significant at 1%, 5% and 10% risk level respectively.
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care seeking behavior varies across socioeconomic groups
and it is mostly pro-rich, however private sector is more
pro-rich than the public sector [28,29]. Difference in
healthcare seeking behavior across socioeconomic groups
can be explained by variation in the degree of health
awareness, physical access to healthcare facilities, eco-
nomic hardship and so forth [29]. On the contrary, private
provisions which are mostly occupied with out-of-pocket
expenditure on healthcare lack redistributive capacity. It
implies that a larger public sector with larger pooled fund
will increase the scope of redistribution of healthcare re-
sources across rich and poor as well as across healthy and
sick people.
The Director General of the World Health Organization
Dr. Margaret Chen in her speech in the Ministerial meet-
ing on universal health coverage in February 2013 empha-
sized strongly on political commitment as well as an
integrated effort at national level, saying that “Progress to-
wards universal coverage cannot be achieved by health
ministers acting alone, even in the presence of political
commitment at the highest level of government. It requires
a concerted national effort, with an especially close engage-
ment of ministers of health and finance” [30].
Since previous studies as well as the current one
indicated that citizens were more sensitive to privatehealthcare expenditure in relation with their income
(income-elastic), governments in SEAR countries should
seriously revisit the current way of involvement of private
healthcare in healthcare financing system and try to re-
organize both private and public sectors in a way so that
equity in healthcare utilization across income-groups could
be addressed. Such an action could address the political
commitment and national effort towards universal health
coverage.
Conclusions
The citizens of SEAR countries consider healthcare as a
necessity while provided through public sector and a
luxury while delivered by private sector.
Endnotes
aStructural Adjustment Programmes (SAPs) are eco-
nomic policies for developing countries that have been
promoted by the World Bank and International Monetary
Fund (IMF) since the early 1980s by the provision of loans
conditional on the adoption of such policies. Structural ad-
justment loans are loans made by the World Bank (source:
http://www.who.int/trade/glossary/story084/en/, accessed
on the 20th November 2014.
bAn income elasticity greater than one usually means
that a good is perceived as a “luxury” good and income
Khan and Mahumud Health Economics Review  (2015) 5:3 Page 9 of 9elastic. An income elasticity between 0 and 1 is a normal
good and income inelastic meaning that it does not re-
spond as much to income changes and therefore is per-
ceived as more of a necessity.
cPublic health expenditure consists of recurrent and
capital spending from government (central and local)
budgets, external borrowings and grants (including
donations from international agencies and nongovern-
mental organizations), and social (or compulsory) health
insurance funds. Private health expenditure includes direct
household (out-of-pocket) spending, private insurance,
charitable donations, and direct service payments by pri-
vate corporations (Source: World Development Indicators,
The World Bank, 2014).
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